Ventas, Inc. (VTR), headquartered in Chicago, Illinois, is a leading real estate investment trust (REIT) enabling exceptional environments that benefit a large and growing aging population. Valued at $24.7 billion by market cap, the company owns seniors housing communities, skilled nursing facilities, hospitals, and medical office buildings in the U.S. and Canada.
Companies worth $10 billion or more are generally described as “large-cap stocks,” and VST perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the REIT - healthcare facilities industry. Ventas' diversified portfolio provides resilience against market fluctuations, with strong rental income from triple-net leased properties and outpatient medical and research facilities. Their strategic investments in mature healthcare markets like Canada and the United Kingdom offer long-term growth potential.
Despite its notable strength, VTR slipped 12.8% from its 52-week high of $67.61, achieved on Oct. 31. Over the past three months, VTR stock has declined 8.2%, underperforming the Nasdaq Composite’s ($NASX)10% gains during the same time frame.
In the longer term, shares of VTR rose 16.9% over the past six months, outperforming NASX’s six-month gains of 11.7%. However, the stock climbed 18.1% over the past 52 weeks, underperforming NASX’s solid 31.8% returns over the last year.
To confirm the bullish trend, VTR has been trading above its 200-day moving average since late April. However, the stock is trading below its 50-day moving average since early December.
On Oct. 30, VTR shares closed up marginally after reporting its Q3 results. Its FFO of $0.80 matched the analyst estimates. The company’s revenue was $1.24 billion, surpassing Wall Street forecasts of $1.21 billion. VTR expects full-year FFO in the range of $3.14 to $3.18.
In the competitive arena of REIT - healthcare facilities, Omega Healthcare Investors, Inc. (OHI) has taken the lead over VTR, showing resilience with a 23.6% uptick over the past 52 weeks. However, OHI lagged behind the stock with 14.9% gains over the past six months.
Wall Street analysts are moderately bullish on VTR’s prospects. The stock has a consensus “Moderate Buy” rating from the 19 analysts covering it, and the mean price target of $69.72 suggests a potential upside of 18.3% from current price levels.
On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here. More news from Barchart- Intuit Stock Is Trading Flat - But Shorting One-Month Puts and Calls Yield 1.0%
- Top 3 Dividend Kings Trading at a Deep Discount Today
- 1 Penny Stock Wall Street Expects to Soar 100% in 2025
- Volatility Alert: 10 Stocks Showing High IV Percentile
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
